Physicians' Academy for Cardiovascular Education

High-dose or low dose statin, with ezetimibe or without ezetimibe: where do we go from here in secondary prevention?

Slides (presentation) - June 18, 2015

Presentation prepared and held by Dr Colin Baigent (Oxford, UK) in Xchange session “Epidemiology of CVD and Current Risk Stratification” on Sunday, May 24, 2015 during ISA2015 (Amsterdam, The Netherlands).

To view slides, click on images

Baigent_statins_ezetimibe_and_secondary_prevention_ISA_2015_FINAL.pdf (1,4MB)Baigent_statins_ezetimibe_and_secondary_prevention_ISA_2015.pdf (1,4MB)

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: